Background: Gallbladder cancer (GBC) is an aggressive and highly lethal biliary tract malignancy, with extremely poor prognosis. In the present study, we analyzed the potential involvement of MYBL2, a member of the Myb transcription factor family, in the carcinogenesis of human GBC. Methods: MYBL2 expression levels were measured in GBC and cholecystitis assays. The effects of MYBL2 on cell proliferation and DNA synthesis were evaluated using Cell Counting Kit-8 assay (CCK-8), colony formation, and 5-ethynyl-2'-deoxyuridine (EdU) in nude mice. Results: MYBL2 expression was increased in GBC tissues and associated with histological differentiation , tumour invasion, clinical stage and unfavourable overall survival in GBC patients. The downregulation of MYBL2 expression resulted in the inhibition of GBC cell proliferation, and DNA replication in vitro, and the growth of xenografted tumours in nude mice. Conversely, MYBL2 overexpression resulted in the opposite effects. Conclusions: MYBL2 overexpression promotes GBC cell proliferation through the regulation of the cell cycle at the S and G2/M phase transitions. Thus, MYBL2 could serve as a potential prognostic and therapeutic biomarker in GBC patients.
MYBL2 is a Potential Prognostic Marker that Promotes Cell Proliferation in Gallbladder Cancer
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Introduction
Gallbladder cancer (GBC) , derived from the bile duct epithelium, is the most common malignancy of the biliary tract and the sixth most common gastrointestinal malignancy, GBC patient prognosis must be improved through the development of effective therapeutic , particularly in embryonic stem cells and hepatocellular carcinoma, lung cancer, breast cancer, cervical cancer and colorectal cancer . .
biological functions in GBC have not been previously investigated.
and the poor prognoses of GBC patients, and examined its oncogenic function in vitro and in vivo acts as an independent predictive factor of poor prognosis in GBC patients, contributing to 
